companiesandmarkets.com

Return to Report | Print

XOMA Limited - Premium Company Profile

http://www.companiesandmarkets.com/Summary-Company-Profile/xoma-limited-premium-company-profile-41262.asp

Report Summary

Introduction

XOMA is a biopharmaceutical company focusing on the discovery and development of therapeutic antibodies for the treatment of cancer and immune diseases. The company has a broad technology platform and a fully integrated product development infrastructure for antibodies and other biologics.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    XOMA's technological platform makes the company unique from its competitors. The company's marketed product, Lucentis was developed using its BCE technology and XOMA 052 is the first candidate being developed using another proprietary technology, Human Engineered (HE) technology.

    The company derives its revenues from contract, licensing, collaboration and royalties. These include upfront and milestone payments related to the outlicensing agreement with Merck & Co as well as from contracts entered with SPRI, Taligen, AVEO and NIAID, Genentech and Novartis.

    During 2006-2010, XOMA's revenues are expected to grow at a CAGR of 39% rising from $29 million to $110 million, over the period 2006-2010, XOMA's biggest contributor to sales growth out to 2010 will be from contract, license and collaboration, forecasted to grow at a CAGR of 43% from $19 million in 2006 to $81 million in 2010.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 9
    Company Financials 12
    Stock Market Performance 12
    P&L 14
    Balance Sheet 17
    Cash Flow 17
    Business Segment Performance 18
    Geographic Segment Performance 20
    Products & Services 21
    Marketed Products 21
    Pipeline Products 23
    AC Forecast Product Sales 26
    Competitors and Strategic Business Relationships 28
    Key Competitors 28
    Key Suppliers 29
    Key Clients 29
    Shareholding Structure 31
    Strategy 32
    Company View 32
    Corporate Strategy 35
    SWOT Analysis 37
    Overview 37
    Strengths 38
    Weaknesses 39
    Opportunities 40
    Threats 42
    Value Chain Analysis 43
    Discovery and Product Development 44
    Manufacturing 44
    Scorecard 45
    Overview 45
    Scorecard Analysis 46
    Key Employees 47
    List of Key Employees 47
    Key Employee Biographies 48
    Financial and Operational Overview 55
    Financial and Operational Overview 55
    APPENDIX 57
    Ask the analyst 57
    Datamonitor consulting 57
    Disclaimer 57


    TABLE OF FIGURES
    Figure 1: XOMA - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15
    Figure 2: XOMA - Key Strategic Revenues, 2002-2006 ($ Mn) 19
    Figure 3: XOMA- Key Strategic Revenues, 2006-2010 ($ Mn) 27


    TABLE OF TABLES
    Table 1: XOMA- Key Facts 6
    Table 2: XOMA - Year-End Share Price and Market Capitalization, 2002-2006 ($) 12
    Table 3: XOMA - Key Events Impacting Share Price Performance 13
    Table 4: XOMA - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
    Table 5: XOMA - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 16
    Table 6: XOMA - Balance Sheet, 2002-2006 ($ Mn) 17
    Table 7: XOMA - Cash Flow, 2002-2006 ($ Mn) 17
    Table 8: XOMA - Revenue Breakdown by Division, 2002-2006 ($ Mn) 18
    Table 9: XOMA - Geographic Breakdown, 2002-2006 ($ Mn) 20
    Table 10: XOMA - Marketed Products 21
    Table 11: XOMA - In-house Pipeline Products 23
    Table 12: XOMA - Collaborative Pipeline Products 24
    Table 13: XOMA - Forecast Sales, 2006-2010 ($ Mn) 26
    Table 14: XOMA - Key Competitors 28
    Table 15: XOMA - Key Suppliers 29
    Table 16: XOMA - Key Clients 30
    Table 17: XOMA - Key Shareholders 31
    Table 18: XOMA - SWOT Analysis Summary 37
    Table 19: XOMA - Value Chain Analysis 43
    Table 20: XOMA - Scorecard 45
    Table 21: XOMA - Key Employees 47
    Table 22: XOMA - Financial and Operational Overview 55